American Bio Medica Corporation

ABMC · OTC
Analyze with AI
3/31/2023
12/31/2022
9/30/2022
6/30/2022
Operating Activities
Net Income$1,881-$317-$314-$400
Dep. & Amort.$8$13$12$13
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$138-$286$231$336
Other Non-Cash-$2,114-$21-$4-$18
Operating Cash Flow-$363-$611-$75-$69
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$247$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$247$0$0$0
Financing Activities
Debt Repay.$150$635$83$54
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$150$635$83$54
Forex Effect$0$0$0$0
Net Chg. in Cash$34$24$8-$15
Supplemental Information
Beg. Cash$34$10$2$17
End Cash$68$34$10$2
Free Cash Flow-$363-$611-$75-$69